{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:03:10Z","timestamp":1771945390644,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Endometrial stromal sarcoma (ESS) is a rare malignant tumor. There is insufficient data supporting the efficiency of current treatments in multiple metastatic settings, and novel therapeutic options for ESS are considered an area of high unmet clinical need.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report the case of a 28-year-old woman who was diagnosed with ESS after undergoing total hysterectomy and left adnexectomy at another hospital. Two years later, the disease recurred, with multiple abdominal cavities and lung metastases. The patient was treated with a variety of chemotherapeutic drugs, including tyrosine kinase inhibitors, at the same hospital; however, none of them inhibited disease progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Computed tomography (CT) revealed multiple masses in the abdominal and pelvic cavities and multiple pulmonary nodules. Ultrasound-guided biopsy was performed and the tumor tissue was histologically confirmed after treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Insulin 300\u2013400 IU was administrated by intravenous infusion in 10% glucose (500\u2009mL) with disodium adenosine triphosphate 60\u2009mg, coenzyme A 100 units, 10% potassium chloride 5\u2009mL and 25% magnesium sulfate 5\u2009mL. Dexamethasone (20\u201325\u2009mg\/d) was diluted with 10\u2009mL of 2% lidocaine and then intraperitoneally injected after ascites draw. After 9 months, the patient was referred to another center for radiotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>CT images tomography showed recurrent pelvic masses, and multiple abdominal cavity and lung metastases gradually shrunk with treatment. Histological biopsy revealed growth arrest of tumor cells. The patient experienced for 3-years survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>High-dose insulin and dexamethasone combined with radiotherapy provides a novel and promising option for patients with multiple ESS metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033525","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T14:02:44Z","timestamp":1681480964000},"page":"e33525","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["High-dose insulin and dexamethasone combined with radiotherapy in endometrial stromal sarcoma recurring with multiple metastases: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Libin","family":"Liang","sequence":"first","affiliation":[{"name":"Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[{"name":"Graduate school of Hebei Medical University, Shijiazhuang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Xu","sequence":"additional","affiliation":[{"name":"Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lansen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehui","family":"Liu","sequence":"additional","affiliation":[{"name":"Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-2703","authenticated-orcid":false,"given":"Xinglong","family":"Tong","sequence":"additional","affiliation":[{"name":"Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0971-5851.96960","article-title":"Endometrial stromal sarcoma: a review of the literature.","volume":"33","author":"Puliyath","year":"2012","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.12998\/wjcc.v7.i14.1753","article-title":"Current status of the adjuvant therapy in uterine sarcoma: a literature review.","volume":"7","author":"Rizzo","year":"2019","journal-title":"World J Clin Cases"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5603\/GP.2016.0051","article-title":"Systemic therapy for endometrial stromal sarcomas: current treatment options.","volume":"87","author":"Serkies","year":"2016","journal-title":"Ginekol Pol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.critrevonc.2017.12.009","article-title":"Systemic treatment in adult uterine sarcomas.","volume":"122","author":"Desar","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/diagnostics11030429","article-title":"Update on endometrial stromal tumours of the uterus.","volume":"11","author":"Akaev","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2004.12.003","article-title":"Hormonal treatment with aromatase inhibitors for patients with endometrial stromal sarcoma.","volume":"98","author":"Reich","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(00)01369-9","article-title":"Radiation therapy in the treatment of endometrial stromal sarcoma.","volume":"49","author":"Weitmann","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/CMAR.S187849","article-title":"High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis.","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bcp.15641","article-title":"High-dose insulin should be used before vasopressors\/inotropes in calcium-channel blocker toxicity.","volume":"89","author":"M\u00e9garbane","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/ol.2016.5422","article-title":"Inhibitory effect of dexamethasone on residual Lewis lung cancer cells in mice following palliative surgery.","volume":"13","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1158\/0008-5472.CAN-07-6104","article-title":"Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.","volume":"68","author":"Yemelyanov","year":"2008","journal-title":"Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:39:49Z","timestamp":1746326389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":11,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033525","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}